FENC - Fennec Pharmaceuticals Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Fennec Pharmaceuticals GAAP EPS of -$0.19
• Fennec Pharmaceuticals secures up to $45M financing facility from Petrichor
• Fennec Pharmaceuticals GAAP EPS of -$0.14 in-line
• Fennec refiling gets FDA review for Pedmark to prevent chemotherapy-induced hearing loss in children
• Fennec refiles for FDA approval of Pedmark for preventing ototoxicity due to chemotherapy
• Fennec Pharmaceuticals GAAP EPS of -$0.18
• Fennec Pharma commercial chief to depart in February
• Fennec Pharma receives FDA CRL for Pedmark application in solid tumors
• Fennec Pharma down 40% as company expects to receive FDA Complete Response Letter for Pedmark
• Fennec Pharmaceuticals EPS beats by $0.01
• Fennec Pharmaceuticals EPS beats by $0.04
• Fennec Pharmaceuticals increases existing senior debt facility to $20M
• FDA accepts Fennec Pharma's resubmitted PEDMARK application, shares rise 17%
• Fennec Pharma resubmits PEDMARK application in U.S.
• Fennec Pharmaceuticals EPS beats by $0.03
• Fennec Pharmaceuticals EPS beats by $0.08
• Fennec Pharmaceuticals EPS misses by $0.05
• Fennec Pharma craters on FDA rejection of Pedmark application
• Fennec Pharmaceuticals EPS misses by $0.03
• Fennec Pharmaceuticals boosts size of debt facility